Health
Diabetes drug can treat and reverse heart failure and reduce – EurekAlert
Mount Sinai clinical trial results could help lead to FDA approval
Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.
Their clinical trial showed that this medication can improve the heart’s size, shape, and function, leading to better exercise capacity and quality of life, which will reduce hospitalizations for heart failure patients. The results were presented on Friday, November 13, at the American…
-
Noosa News23 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
General24 hours agoDonald Trump and the ghost of Al Capone • Inside Story
-
General24 hours agoFire razes Tumby Bay hardware store with damage likely to exceed $1m
-
Noosa News8 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites